These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2894715)

  • 21. Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections. German and Austrian Imipenem/Cilastatin Study Group.
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):683-92. PubMed ID: 1425726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
    Garau J; Blanquer J; Cobo L; Corcia S; Daguerre M; de Latorre FJ; León C; Del Nogal F; Net A; Rello J
    Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):789-96. PubMed ID: 9447899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbapenems: monotherapy in intra-abdominal sepsis.
    Wilson SE
    Scand J Infect Dis Suppl; 1995; 96():28-33. PubMed ID: 7652500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of imipenem/cilastatin for treatment of infection in an elderly population.
    Smith MD; Bielawska C; Kelsey MC; Rai G; Deaney NB
    J Antimicrob Chemother; 1988 Apr; 21(4):481-7. PubMed ID: 3378960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
    Lode H; Wiley R; Höffken G; Wagner J; Borner K
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1491-6. PubMed ID: 3324956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
    Uhari M; Seppänen J; Heikkinen E
    Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imipenem: a new carbapenem antibiotic.
    Lipman B; Neu HC
    Med Clin North Am; 1988 May; 72(3):567-79. PubMed ID: 3280907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dosage of imipenem/cilastatin].
    Shah PM
    Infection; 1986; 14 Suppl 2():S143-7. PubMed ID: 3759249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
    Walters DJ; Solomkin JS; Paladino JA
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):551-61. PubMed ID: 10662480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
    Mortimer J; Miller S; Black D; Kwok K; Kirby WM
    Am J Med; 1988 Jul; 85(1A):17-20. PubMed ID: 3400679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F; Faulkner KL
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imipenem-cilastatin as initial therapy for febrile cancer patients.
    Bodey GP; Alvarez ME; Jones PG; Rolston KV; Steelhammer L; Fainstein V
    Antimicrob Agents Chemother; 1986 Aug; 30(2):211-4. PubMed ID: 3532942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imipenem/cilastatin versus gentamicin/clindamycin: a cost effectiveness study.
    Norrby SR; Eriksson M; Ottosson E
    Scand J Infect Dis; 1986; 18(4):371-4. PubMed ID: 3094139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imipenem-cilastatin sodium.
    Stene R
    Iowa Med; 1986 Sep; 76(9):432-7. PubMed ID: 3771166
    [No Abstract]   [Full Text] [Related]  

  • 36. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipenem/cilastatin: its use in the treatment of foot infections in the compromised host.
    Ross CD; Pantig-Felix L; Kanat IO
    J Am Podiatr Med Assoc; 1988 Jul; 78(7):361-7. PubMed ID: 3042952
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients.
    Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; Antúnez de Mayolo E
    Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role for newer beta-lactam antibiotics in treatment of osteomyelitis.
    Gentry LO
    Am J Med; 1985 Jun; 78(6A):134-9. PubMed ID: 3859212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.